390 related articles for article (PubMed ID: 33670126)
1. Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options.
Rajapaksha IG; Gunarathne LS; Angus PW; Herath CB
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33670126
[TBL] [Abstract][Full Text] [Related]
2. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
[TBL] [Abstract][Full Text] [Related]
3. Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension.
Shim KY; Eom YW; Kim MY; Kang SH; Baik SK
Korean J Intern Med; 2018 May; 33(3):453-461. PubMed ID: 29462546
[TBL] [Abstract][Full Text] [Related]
4. Blockade of Mas Receptor or Mas-Related G-Protein Coupled Receptor Type D Reduces Portal Pressure in Cirrhotic but Not in Non-cirrhotic Portal Hypertensive Rats.
Gunarathne LS; Angus PW; Herath CB
Front Physiol; 2019; 10():1169. PubMed ID: 31607942
[TBL] [Abstract][Full Text] [Related]
5. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics.
Gunarathne LS; Rajapaksha H; Shackel N; Angus PW; Herath CB
World J Gastroenterol; 2020 Oct; 26(40):6111-6140. PubMed ID: 33177789
[TBL] [Abstract][Full Text] [Related]
6. Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options.
Grace JA; Herath CB; Mak KY; Burrell LM; Angus PW
Clin Sci (Lond); 2012 Aug; 123(4):225-39. PubMed ID: 22548407
[TBL] [Abstract][Full Text] [Related]
7. Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.
Lubel JS; Herath CB; Burrell LM; Angus PW
J Gastroenterol Hepatol; 2008 Sep; 23(9):1327-38. PubMed ID: 18557800
[TBL] [Abstract][Full Text] [Related]
8. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
9. Activation of the Alternate Renin-Angiotensin System Correlates with the Clinical Status in Human Cirrhosis and Corrects Post Liver Transplantation.
Casey S; Schierwagen R; Mak KY; Klein S; Uschner F; Jansen C; Praktiknjo M; Meyer C; Thomas D; Herath C; Jones R; Trebicka J; Angus P
J Clin Med; 2019 Mar; 8(4):. PubMed ID: 30934723
[TBL] [Abstract][Full Text] [Related]
10. Pathways of hepatic and renal damage through non-classical activation of the renin-angiotensin system in chronic liver disease.
Sansoè G; Aragno M; Wong F
Liver Int; 2020 Jan; 40(1):18-31. PubMed ID: 31580514
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-(1-7): A Novel Peptide to Treat Hypertension and Nephropathy in Diabetes?
Padda RS; Shi Y; Lo CS; Zhang SL; Chan JS
J Diabetes Metab; 2015 Oct; 6(10):. PubMed ID: 26793405
[TBL] [Abstract][Full Text] [Related]
12. Mas-related G protein-coupled receptor type D antagonism improves portal hypertension in cirrhotic rats.
Gunarathne LS; Rajapaksha IG; Casey S; Qaradakhi T; Zulli A; Rajapaksha H; Trebicka J; Angus PW; Herath CB
Hepatol Commun; 2022 Sep; 6(9):2523-2537. PubMed ID: 35593203
[TBL] [Abstract][Full Text] [Related]
13. N-Acetyl-Seryl-Asparyl-Lysyl-Proline regulates lung renin angiotensin system to inhibit epithelial-mesenchymal transition in silicotic mice.
Li S; Li Y; Zhang Y; Li S; Zhang M; Jin F; Wei Z; Yang Y; Gao X; Mao N; Ge X; Xu H; Yang F
Toxicol Appl Pharmacol; 2020 Dec; 408():115255. PubMed ID: 33007385
[TBL] [Abstract][Full Text] [Related]
14. Role of non-classical renin-angiotensin system axis in renal fibrosis.
Lv LL; Liu BC
Front Physiol; 2015; 6():117. PubMed ID: 25954204
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.
Lubel JS; Herath CB; Tchongue J; Grace J; Jia Z; Spencer K; Casley D; Crowley P; Sievert W; Burrell LM; Angus PW
Clin Sci (Lond); 2009 Sep; 117(11):375-86. PubMed ID: 19371232
[TBL] [Abstract][Full Text] [Related]
16. The role of renin-angiotensin system modulation on treatment and prevention of liver diseases.
Moreira de Macêdo S; Guimarães TA; Feltenberger JD; Sousa Santos SH
Peptides; 2014 Dec; 62():189-96. PubMed ID: 25453980
[TBL] [Abstract][Full Text] [Related]
17. Balancing Effect of Biejiajian Oral Liquid () on ACE-Ang II-AT1R Axis and ACE2-Ang-(1-7)-Mas Axis in Rats with CCl
Li XY; Peng Y; Bu XW; Yao J; Yao L
Chin J Integr Med; 2018 Nov; 24(11):853-859. PubMed ID: 29335866
[TBL] [Abstract][Full Text] [Related]
18. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
Li XC; Zhang J; Zhuo JL
Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system.
Cui C; Xu P; Li G; Qiao Y; Han W; Geng C; Liao D; Yang M; Chen D; Jiang P
Redox Biol; 2019 Sep; 26():101295. PubMed ID: 31421410
[TBL] [Abstract][Full Text] [Related]
20. Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations.
Méndez-García LA; Escobedo G; Minguer-Uribe AG; Viurcos-Sanabria R; Aguayo-Guerrero JA; Carrillo-Ruiz JD; Solleiro-Villavicencio H
Front Cell Neurosci; 2022; 16():977039. PubMed ID: 36187294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
